肿胀局麻对DIEP皮瓣乳房重建阿片类药物使用的影响
回顾性研究纳入2019–2023年481例DIEP皮瓣乳房重建患者,比较含布比卡因肿胀局麻(TLA)与标准TAP阻滞。TLA组住院及出院阿片类药物用量显著降低,住院时间缩短,乳房血肿率更低,且不损害疼痛控制。
要点
- TLA可降低DIEP重建住院阿片用量29.4 MME及出院处方36.1 MME
- TLA组住院时间3.4天,短于对照组的3.9天
- TLA组乳房血肿率2.2%,低于对照组的6.2%
核心结论
- TLA显著减少DIEP皮瓣乳房重建患者住院和出院阿片类药物使用并缩短住院时间,且不损害疼痛控制。
研究设计与样本
- 回顾性研究,纳入2019–2023年481例DIEP皮瓣乳房重建患者,TLA组271例(56.3%),对照组210例(43.7%)。
主要发现
- TLA组患者更年轻(50.3 vs. 53.7岁;p=0.025),对照组激素治疗(43.8% vs. 34.7%;p=0.047)和既往放疗(52.9% vs. 39.1%;p=0.003)更常见。
- TLA组乳房血肿率更低(2.2% vs. 6.2%;p=0.033)。
- 线性回归显示TLA组住院阿片用量减少29.4 MME(95% CI:-45.29至-13.45;p<0.001),出院阿片处方减少36.1 MME(95% CI:-58.27至-13.98;p=0.001)。
- TLA组住院时间更短(3.4 vs. 3.9天;p<0.001)。
临床怎么用
- 在DIEP皮瓣乳房重建的乳房和腹部供区采用含布比卡因的肿胀局麻(作为TAP、肋间和局部阻滞)可减少阿片类药物用量并缩短住院时间。
局限性
- 需进一步研究评估出院后长期阿片类药物使用和处方续配率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The opioid epidemic, which cost over $1.02 trillion in 2017, continues to be a major public health concern. To improve postoperative pain control and reduce opioid misuse, our team implemented tumescent local anesthesia with bupivacaine (TLA) in DIEP flap breast reconstructions at both breast and abdominal donor sites. METHODS: We conducted a retrospective study of DIEP flap reconstructions from 2019-2023, comparing patients who received TLA (tumescent fluid with bupivacaine as TAP, intercostal, and local blocks) to those who received the standard TAP block alone. Unpaired t-tests and Fisher's Exact tests assessed group differences; multivariable regression models evaluated postoperative complications. RESULTS: A total of 481 patients were included: 271 (56.3%) in the TLA group and 210 (43.7%) in the control group. Patients receiving TLA were younger (50.3 vs. 53.7 years; p=0.025), while hormonal therapy (43.8% vs. 34.7%; p=0.047) and prior radiation (52.9% vs. 39.1%; p=0.003) were more common in controls. TLA patients had lower breast hematoma rates (2.2% vs. 6.2%; p=0.033). Linear regression showed reduced inpatient opioid use (29.4 MME lower; 95% CI: -45.29 to -13.45; p<0.001), discharge opioid prescriptions (36.1 MME lower; 95% CI: -58.27 to -13.98; p=0.001), and shorter hospital stays (3.4 vs. 3.9 days; p<0.001). CONCLUSIONS: TLA significantly reduces inpatient and discharge opioid use and hospital stay length without compromising pain control. Further study is needed to evaluate long-term opioid use and refill rates post-discharge.
引用
- Escobar-Domingo MJ, Mahmoud AA, Bustos VP, et al. The Impact of Tumescent Local Anesthesia on Opioid Use in DIEP Flap Breast Reconstruction. Plast Reconstr Surg. 2026. PMID: 42868666. doi:10.1097/PRS.0000000000013529
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。